How Pregnancy Affects Asthma in Korea: Risk Factors and Adherence Decline.

IF 4.3 2区 医学 Q2 ALLERGY
Myoung-Nam Lim, Jin-Sung Park, Jae-Woo Kwon
{"title":"How Pregnancy Affects Asthma in Korea: Risk Factors and Adherence Decline.","authors":"Myoung-Nam Lim, Jin-Sung Park, Jae-Woo Kwon","doi":"10.4168/aair.2026.18.3.351","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Pregnancy is a well-known trigger for asthma exacerbations, but risk prediction remains limited. This study aimed to evaluate the impact of pregnancy on asthma control, identify risk factors for exacerbations, and assess adherence to asthma management during and after pregnancy in Korea.</p><p><strong>Methods: </strong>Women with asthma who gave birth between 2012 and 2015 in Korea were identified using the Korean National Health Insurance claims database. Asthma was defined as having at least three asthma diagnoses and at least one prescription of medication for asthma within 4 years before pregnancy. Asthma exacerbations during pregnancy were defined as the requirement for oral corticosteroid treatment or hospitalization, or an emergency department visit. A case-control study was conducted to evaluate risk factors for these exacerbations within the overall cohort and, specifically, among women who discontinued asthma medication during pregnancy. Postpartum adherence to asthma medication was also assessed.</p><p><strong>Results: </strong>Among 123,355 women with asthma, 14.8% experienced asthma exacerbation during pregnancy, while 82.9% discontinued asthma medication during pregnancy. Long-term asthma control, spanning the 4 years before conception was more strongly associated with pregnancy outcomes than the 1-year assessment. During pregnancy, poor adherence to asthma treatment was strongly associated with exacerbations, and women who discontinued medication were particularly vulnerable if they had a history of pre-pregnancy exacerbations, moderate to severe rhinitis, multiple gestation, neuropsychiatric disorders, or prior inhaled corticosteroid use. Even after delivery, only 27.4% of asthmatics continued taking asthma medication.</p><p><strong>Conclusions: </strong>This study emphasizes that long-term asthma control and medication maintenance throughout pregnancy are crucial for preventing exacerbations. High-risk women were characterized by comorbidities such as rhinitis, neuropsychiatric disorders, and multiple gestation. These findings underscore the importance of sustained asthma management and patient education not only before and during pregnancy but also throughout the postpartum period.</p>","PeriodicalId":7547,"journal":{"name":"Allergy, Asthma & Immunology Research","volume":"18 3","pages":"351-361"},"PeriodicalIF":4.3000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13226870/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy, Asthma & Immunology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4168/aair.2026.18.3.351","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Pregnancy is a well-known trigger for asthma exacerbations, but risk prediction remains limited. This study aimed to evaluate the impact of pregnancy on asthma control, identify risk factors for exacerbations, and assess adherence to asthma management during and after pregnancy in Korea.

Methods: Women with asthma who gave birth between 2012 and 2015 in Korea were identified using the Korean National Health Insurance claims database. Asthma was defined as having at least three asthma diagnoses and at least one prescription of medication for asthma within 4 years before pregnancy. Asthma exacerbations during pregnancy were defined as the requirement for oral corticosteroid treatment or hospitalization, or an emergency department visit. A case-control study was conducted to evaluate risk factors for these exacerbations within the overall cohort and, specifically, among women who discontinued asthma medication during pregnancy. Postpartum adherence to asthma medication was also assessed.

Results: Among 123,355 women with asthma, 14.8% experienced asthma exacerbation during pregnancy, while 82.9% discontinued asthma medication during pregnancy. Long-term asthma control, spanning the 4 years before conception was more strongly associated with pregnancy outcomes than the 1-year assessment. During pregnancy, poor adherence to asthma treatment was strongly associated with exacerbations, and women who discontinued medication were particularly vulnerable if they had a history of pre-pregnancy exacerbations, moderate to severe rhinitis, multiple gestation, neuropsychiatric disorders, or prior inhaled corticosteroid use. Even after delivery, only 27.4% of asthmatics continued taking asthma medication.

Conclusions: This study emphasizes that long-term asthma control and medication maintenance throughout pregnancy are crucial for preventing exacerbations. High-risk women were characterized by comorbidities such as rhinitis, neuropsychiatric disorders, and multiple gestation. These findings underscore the importance of sustained asthma management and patient education not only before and during pregnancy but also throughout the postpartum period.

妊娠如何影响韩国的哮喘:危险因素和依从性下降。
目的:众所周知,妊娠是哮喘恶化的诱因,但风险预测仍然有限。本研究旨在评估妊娠对哮喘控制的影响,确定哮喘恶化的危险因素,并评估妊娠期间和妊娠后对哮喘管理的依从性。方法:使用韩国国民健康保险索赔数据库确定2012年至2015年间在韩国分娩的哮喘妇女。哮喘被定义为在怀孕前4年内至少有3次哮喘诊断和至少一次哮喘药物处方。妊娠期哮喘加重被定义为需要口服皮质类固醇治疗或住院,或急诊就诊。进行了一项病例对照研究,以评估整个队列中这些加重的危险因素,特别是在怀孕期间停用哮喘药物的妇女中。产后对哮喘药物的依从性也进行了评估。结果:在123355名哮喘女性中,14.8%的人在怀孕期间哮喘加重,而82.9%的人在怀孕期间停用哮喘药物。怀孕前4年的长期哮喘控制与妊娠结局的关系比1年的评估更强。在怀孕期间,哮喘治疗依从性差与病情加重密切相关,如果有孕前病情加重史、中重度鼻炎史、多胎妊娠史、神经精神疾病史或既往吸入性皮质类固醇史,停用药物的妇女尤其容易发生哮喘。即使在分娩后,也只有27.4%的哮喘患者继续服用哮喘药物。结论:本研究强调孕期长期哮喘控制和药物维持对预防哮喘恶化至关重要。高危妇女的特点是合并症,如鼻炎、神经精神障碍和多胎妊娠。这些发现强调了持续哮喘管理和患者教育的重要性,不仅在怀孕前和怀孕期间,而且在整个产后期间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.10
自引率
6.80%
发文量
53
审稿时长
>12 weeks
期刊介绍: The journal features cutting-edge original research, brief communications, and state-of-the-art reviews in the specialties of allergy, asthma, and immunology, including clinical and experimental studies and instructive case reports. Contemporary reviews summarize information on topics for researchers and physicians in the fields of allergy and immunology. As of January 2017, AAIR do not accept case reports. However, if it is a clinically important case, authors can submit it in the form of letter to the Editor. Editorials and letters to the Editor explore controversial issues and encourage further discussion among physicians dealing with allergy, immunology, pediatric respirology, and related medical fields. AAIR also features topics in practice and management and recent advances in equipment and techniques for clinicians concerned with clinical manifestations of allergies and pediatric respiratory diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书